Close
  Indian J Med Microbiol
 

Figure 1: Demographic and outcome of 5 randomized trials on implantable cardioverter defibrillator in nonischemic dilated cardiomyopathy patients: Cardiomyopathy trial (CAT),[3] amiodarone versus implantable cardioverter–defibrillator trial (AMIOVIRT),[4] defibrillators in nonischemic cardiomyopathy treatment evaluation DEFINITE,[5] sudden cardiac death-Heart Failure Trial SCD-HeFT,[6] and defibrillator implantation in patients with nonischemic systolic heart failure (DANISH).[9] COMPANION[8] is a trial on cardiac resynchronization therapy defibrillator versus cardiac resynchronization therapy in a more advanced heart failure population and is shown for comparison. These trials have included a total of 104, 103, 458, 2571, 1116, and 1520 patients, respectively (listed in parenthesis).[3],[4],[5],[6],[8],[9] EF = ejection fraction, FU = follow-up

Figure 1: Demographic and outcome of 5 randomized trials on implantable cardioverter defibrillator in nonischemic dilated cardiomyopathy patients: Cardiomyopathy trial (CAT),<sup>[3]</sup> amiodarone versus implantable cardioverter–defibrillator trial (AMIOVIRT),<sup>[4]</sup> defibrillators in nonischemic cardiomyopathy treatment evaluation DEFINITE,<sup>[5]</sup> sudden cardiac death-Heart Failure Trial SCD-HeFT,<sup>[6]</sup> and defibrillator implantation in patients with nonischemic systolic heart failure (DANISH).<sup>[9]</sup> COMPANION<sup>[8]</sup> is a trial on cardiac resynchronization therapy defibrillator versus cardiac resynchronization therapy in a more advanced heart failure population and is shown for comparison. These trials have included a total of 104, 103, 458, 2571, 1116, and 1520 patients, respectively (listed in parenthesis).<sup>[3],[4],[5],[6],[8],[9]</sup> EF = ejection fraction, FU = follow-up